ANI Pharmaceuticals, Inc. (ANIP)
81.67
+0.33
(+0.41%)
USD |
NASDAQ |
Dec 09, 16:00
81.64
-0.03
(-0.04%)
After-Hours: 20:00
ANI Pharmaceuticals EPS Diluted (Quarterly): 1.133 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| Intellia Therapeutics, Inc. | -0.9196 |
| Beam Therapeutics, Inc. | -1.099 |
| Halozyme Therapeutics, Inc. | 1.432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 24.13M |
| Revenue (Quarterly) | 227.81M |
| Total Expenses (Quarterly) | 203.68M |
| Enterprise Value | 2.194B |
| Gross Profit Margin (Quarterly) | 49.07% |
| Profit Margin (Quarterly) | 10.59% |
| Earnings Yield | 2.00% |
| Operating Earnings Yield | 3.24% |
| Normalized Earnings Yield | 1.214 |